Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) logo Bentham Science Publishers logo

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 4, December 2010

< previous issue | all issues | next issue >


Wound-Associated Skin Fibrosis: Mechanisms and Treatments Based on Modulating the Inflammatory Response
pp. 320-330(11)
Authors: J. Shaw, Tanya; Kishi, Kazuo; Mori, Ryoichi

Fibrosis in the Anterior Segments of the Eye
pp. 331-335(5)
Authors: Yamanaka, Osamu; Liu, Chia-Yang; W.-Y. Kao, Winston

The Leptin System: A Potential Target for Sepsis Induced Immune Suppression
pp. 336-347(12)
Authors: Tschop, Johannes; R. Dattilo, Jonathan; S. Prakash, Priya; R. Kasten, Kevin; H. Tschop, Matthias; C. Caldwell, Charles

Free Content Isoforms of Vitamin E Differentially Regulate Inflammation
pp. 348-366(19)
Authors: M. Cook-Mills, Joan; A. McCary, Christine

PKC- is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection
pp. 367-372(6)
Authors: Kwon, Myung-Ja; Wang, Ruiqing; Ma, Jian; Sun, Zuoming

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page